Results 11 to 20 of about 16,593 (260)

Nanobody mediated inhibition of attachment of F18 fimbriae expressing Escherichia coli [PDF]

open access: yes, 2014
Post-weaning diarrhea and edema disease caused by F18 fimbriated E. coli are important diseases in newly weaned piglets and lead to severe production losses in farming industry.
Coddens, Annelies   +6 more
core   +8 more sources

Electrochemical detection of Toxocara canis excretory-secretory antigens in children from rural communities in Esmeraldas Province, Ecuador: association between active infection and high eosinophilia. [PDF]

open access: yes, 2020
BACKGROUND: The diagnosis of active Toxocara canis infections in humans is challenging. Larval stages of T. canis do not replicate in human tissues and disease may result from infection with a single T. canis larva.
Chico, M   +9 more
core   +3 more sources

Immunogenicity Risk Profile of Nanobodies [PDF]

open access: yesFrontiers in Immunology, 2021
Nanobodies (Nbs), the variable domains of camelid heavy chain-only antibodies, are a promising class of therapeutics or in vivo imaging reagents entering the clinic. They possess unique characteristics, including a minimal size, providing fast pharmacokinetics, high-target specificity, and an affinity in the (sub-)nanomolar range in conjunction with an
Chloé Ackaert   +17 more
openaire   +5 more sources

Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy

open access: yesJournal of Immunology Research, 2020
Retargeting the antigen-binding specificity of T cells to intracellular antigens that are degraded and presented on the tumor surface by engineering chimeric antigen receptor (CAR), also named TCR-like antibody CAR-T, remains limited.
Lichen Zhu   +15 more
doaj   +1 more source

Improved detection of molecular markers of atherosclerotic plaques using sub-millimeter PET imaging [PDF]

open access: yes, 2020
Since atherosclerotic plaques are small and sparse, their non-invasive detection via PET imaging requires both highly specific radiotracers as well as imaging systems with high sensitivity and resolution.
Bormans, Guy   +11 more
core   +2 more sources

Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2018
Objective(s): Nanobodies, the single domain antigen binding fragments of heavy chain-only antibodies occurring naturally in camelid sera, are the smallest intact antigen binding entities.
Fatemeh Kazemi-Lomedasht   +3 more
doaj   +1 more source

Description of a nanobody-based competitive immunoassay to detect tsetse fly exposure [PDF]

open access: yes, 2015
Background : Tsetse flies are the main vectors of human and animal African trypanosomes. The Tsal proteins in tsetse fly saliva were previously identified as suitable biomarkers of bite exposure.
Caljon, Guy   +3 more
core   +11 more sources

Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification

open access: yes, 2022
Nanobodies have recently been introduced to the field of photodynamic therapy (PDT) as a very promising strategy to target photosensitizers selectively to cancer cells. Nanobodies are known for their characteristic small size (15 kDa), high specificity, and high binding affinities.
Mashayekhi, Vida   +4 more
openaire   +4 more sources

Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4

open access: yesBMC Cancer, 2022
Background: Antibodies and derivative drugs targeting immune checkpoints have been approved for the treatment of several malignancies, but there are fewer responses in patients with pancreatic cancer.
Shuai Hao   +10 more
doaj   +1 more source

A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo

open access: yesFrontiers in Oncology, 2021
Breast cancer is the most common malignant cancer in women worldwide, especially in developing countries. Herceptin is a monoclonal antibody with an antitumor effect in HER2-positive breast cancer. However, the large molecular weight of Herceptin limited
Yan Yan   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy